(14β,17α)-3-methoxyestra-1,3,5(10)-triene-17-methanol | 116948-87-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (14β,17α)-3-methoxyestra-1,3,5(10)-triene-17-methanol
• 英文别名: (14beta,17alpha)-3-Methoxyestra-1,3,5(10)-triene-17-methanol；[(8S,9S,13S,14R,17R)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]methanol
• CAS: 116948-87-9
• 化学式: C₂₀H₂₈O₂
• 分子量: 300.441
• InChiKey: FSKRAXFONXVCRH-MLCHDBGUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (14β,17α)-3-methoxyestra-1,3,5(10)-triene-17-methanol 、 异丙醇 在 三乙胺 作用下， 以 二甲基亚砜 为溶剂， 生成 (14β,17α)-3-methoxyestra-1,3,5(10)-triene-17-carboxaldehyde
  参考文献：
  名称：

  14.BETA.,17-ALPHA-HYDROXYMETHYLANDROSTANE DERIVATIVES AS ANDROGENS

  摘要：

  公开号：

  EP1163259B1

文献信息

• 14-β, 17-α-hydroxymethylandrostane derivatives as androgens
  申请人：Loozen Hubert Jan Jozef

  公开号：US06881728B1

  公开（公告）日：2005-04-19

  Androgenic steroids having a (14β,17α-)-17-(hydroxymetheyl) configuration, useful for the preparation of male contraceptives and pharmaceutical formulations for the treatment of androgen insufficiency.

  雄激素类固醇具有（14β，17α-）-17-（羟甲基）配置，可用于制备男性避孕药和用于治疗雄激素不足的制药配方。
• US6881728B1
  申请人：——

  公开号：US6881728B1

  公开（公告）日：2005-04-19
• [EN] 14.BETA., 17-ALPHA-HYDROXYMETHYLANDROSTANE DERIVATIVES AS ANDROGENS<br/>[FR] DERIVES DE 14.BETA., ALPHA-HYDROXYMETHYLANDROSTANE INTERVENANT COMME ANDROGENES
  申请人：AKZO NOBEL NV

  公开号：WO2000053619A1

  公开（公告）日：2000-09-14

  The disclosed invention relates to the unexpected finding of steroids for use as androgens which are characterized by a configuration opposite to that of natural steroids, viz. 14α, 17β. These steroids according to the invention are (14β, 17α)-17-(hydroxymethyl) steroids, and they are found to have in common an androgenic activity. They can be used for the preparation of an agent for male contraception, as well as for the preparation of a medicament for the treatment of androgen insufficiency.
• 14.BETA.,17-ALPHA-HYDROXYMETHYLANDROSTANE DERIVATIVES AS ANDROGENS
  申请人：Akzo Nobel N.V.

  公开号：EP1163259B1

  公开（公告）日：2002-11-20